Report
David Seynnaeve, PhD

Onward Medical NV - Providing comfort on ARC-EX launch

*This morning, ONWD announced its 2024 priorities and released key financial highlights *Importantly, ONWD reiterated 1/ its Q4 launch timing for ARC-EX and 2/ 2024 launch of the pivotal study Empower-BP for blood pressure management *No impact on estimates and valuation; Buy rating reiterated. We expect a positive share price reaction as the approval & launch of ARC-EX was one of the main concerns of investors as launch was previously pushed twice
Underlying
ONWARD MEDICAL NV

Provider
Degroof Petercam
Degroof Petercam

​We are an investment house with Belgian roots founded on more than 150 years of trust.

As a private company owned by long-term committed shareholders, we are independent. Naturally and structurally. Our experts have the knowledge to think and act without bias, and to make decisions that benefit our clients. Today and tomorrow.

Analysts
David Seynnaeve, PhD

Other Reports on these Companies
Other Reports from Degroof Petercam

ResearchPool Subscriptions

Get the most out of your insights

Get in touch